Diosmin for Treatment of Menorrhagia in Women Using Copper IUD | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 252, Volume 89, Issue 1, October 2022, Page 5728-5732 PDF (736.01 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2022.266037 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Rahma Aly Mohammed 
| ||||
| Abstract | ||||
| Background: Many ladies deal with the difficulty of menorrhagia. Among women aged 30 to 49 years, one in twenty suffers from menorrhagia, with 30% claiming their IUD is to blame for 10% to 15% of their bleeding. Objectives: This study aimed to determine if diosmin is effective in lowering menstrual blood loss in IUCD-afflicted women who have menorrhagia. Patients and methods: One hundred ladies were enrolled in this clinical trial investigation. They were selected among the women who went to the Family Planning Clinic, Ain Shams University's School of Medicine. They were complaining of heavy periods after switching to a copper IUCD. The study was conducted during the period from October 2015 to August 2016. Results: However, there was statistical significant difference between bleeding before therapy and after the first cycle of treatment in both groups, but no difference in bleeding during the first, second, or third cycles of treatment. However, there were notable differences in the groups' mean bleeding days before and after therapy. Conclusion: Diosmin is a drug that is beneficial in reducing the increased menstrual blood loss in women who are using copper IUDs, according to the study's findings. | ||||
| Keywords | ||||
| Diosmin; Menorrhagia; Copper IUD | ||||
|
Statistics Article View: 270 PDF Download: 1,769 |
||||
